The Significance of Fibrinogen in Combination with the Neutrophil to Lymphocyte Ratio in Predicting the Prognosis of Patients with Gastric Cancer

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Zuo T, et al. National cancer incidence and mortality in China, 2012. Chin J Cancer Res. 2016;28(1):1–11. doi:10.3978/j.issn.1000-9604.2016.02.08
   PubMed Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. doi:10.3322/caac.21262
   PubMed Web of Science ®Google Scholar
• Hashimoto T, Kurokawa Y, Mori M, et al. Update on the treatment of gastric cancer. JMA J. 2018;1(1):40–49.
   PubMedGoogle Scholar
• Kurokawa Y, Doki Y, Mizusawa J, et al. Bursectomy versus omentectomy alone for resectable gastric cancer (JCOG1001): a phase 3, open-label, randomised controlled trial. Lancet Gastroenterol Hepatol. 2018;3(7):460–468. doi:10.1016/S2468-1253(18)30090-6
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Kurokawa Y, Kobayashi N, et al. Prognostic value of the combined index of plasma fibrinogen and the neutrophil-lymphocyte ratio in gastric cancer. World J Surg. 2020;44(1):207–212. doi:10.1007/s00268-019-05193-7
   PubMed Web of Science ®Google Scholar
• Matsuoka T, Yashiro M. Biomarkers of gastric cancer: current topics and future perspective. World J Gastroenterol. 2018;24(26):2818–2832. doi:10.3748/wjg.v24.i26.2818
   PubMed Web of Science ®Google Scholar
• Huang W, Wang S, Zhang H, et al. Prognostic significance of combined fibrinogen concentration and neutrophil-to-lymphocyte ratio in patients with resectable non-small cell lung cancer. Cancer Biol Med. 2018;15(1):88–96. doi:10.20892/j.issn.2095-3941.2017.0124
   PubMed Web of Science ®Google Scholar
• Kijima T, Arigami T, Uchikado Y, et al. Combined fibrinogen and neutrophil-lymphocyte ratio as a prognostic marker of advanced esophageal squamous cell carcinoma. Cancer Sci. 2017;108(2):193–199. doi:10.1111/cas.13127
   PubMed Web of Science ®Google Scholar
• Liu X, Liu Z, Lin E, et al. A cumulative score based on preoperative fibrinogen and the neutrophil–lymphocyte ratio to predict outcomes in resectable gastric cancer. Cancer Manag Res. 2018;10:3007–3014. doi:10.2147/CMAR.S174656
   PubMed Web of Science ®Google Scholar
• Palaj J, Keckes S, Marek V, et al. Fibrinogen levels are associated with lymph node involvement and overall survival in gastric cancer patients. Anticancer Res. 2018;38(2):1097–1104. doi:10.21873/anticanres.12328
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Kurokawa Y, Miyazaki Y, et al. Usefulness of preoperative plasma fibrinogen versus other prognostic markers for predicting gastric cancer recurrence. World J Surg. 2016;40(8):1904–1909. doi:10.1007/s00268-016-3474-5
   PubMed Web of Science ®Google Scholar
• Afghahi A, Purington N, Han SS, et al. Higher absolute lymphocyte counts predict lower mortality from early-stage triple-negative breast cancer. Clin Cancer Res. 2018;24(12):2851–2858. doi:10.1158/1078-0432.CCR-17-1323
   PubMed Web of Science ®Google Scholar
• Botta C, Barbieri V, Ciliberto D, et al. Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients. Cancer Biol Ther. 2013;14(6):469–475. doi:10.4161/cbt.24425
   PubMed Web of Science ®Google Scholar
• Pang W, Lou N, Jin C, et al. Combination of preoperative platelet/lymphocyte and neutrophil/lymphocyte rates and tumor-related factors to predict lymph node metastasis in patients with gastric cancer. Eur J Gastroenterol Hepatol. 2016;28(5):493–502. doi:10.1097/MEG.0000000000000563
   PubMed Web of Science ®Google Scholar
• Xin-Ji Z, Yong-Gang L, Xiao-Jun S, et al. The prognostic role of neutrophils to lymphocytes ratio and platelet count in gastric cancer: a meta-analysis. Int J Surg. 2015;21:84–91. doi:10.1016/j.ijsu.2015.07.681
   PubMed Web of Science ®Google Scholar
• Greten FR, Grivennikov SI. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity. 2019;51(1):27–41. doi:10.1016/j.immuni.2019.06.025
   PubMed Web of Science ®Google Scholar
• Miyamoto R, Inagawa S, Sano N, et al. The neutrophil-to-lymphocyte ratio (NLR) predicts short-term and long-term outcomes in gastric cancer patients. Eur J Surg Oncol. 2018;44(5):607–612. doi:10.1016/j.ejso.2018.02.003
   PubMed Web of Science ®Google Scholar
• Zhao LY, Zhao YL, Wang JJ, et al. Is preoperative fibrinogen associated with the survival prognosis of gastric cancer patients? A multi-centered, propensity score-matched retrospective study. World J Surg. 2020;44(1):213–222. doi:10.1007/s00268-019-05191-9
   PubMed Web of Science ®Google Scholar
• Yu X, Hu F, Yao Q, et al. Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study. BMC Cancer. 2016;16:480. doi:10.1186/s12885-016-2510-z
   PubMed Web of Science ®Google Scholar
• Wang H, Zhao J, Zhang M, et al. The combination of plasma fibrinogen and neutrophil lymphocyte ratio (F-NLR) is a predictive factor in patients with resectable non small cell lung cancer. J Cell Physiol. 2018;233(5):4216–4224. doi:10.1002/jcp.26239
   PubMed Web of Science ®Google Scholar
• Tsai PL, Su WJ, Leung WH, et al. Neutrophil-lymphocyte ratio and CEA level as prognostic and predictive factors in colorectal cancer: a systematic review and meta-analysis. J Cancer Res Ther. 2016;12(2):582–589. doi:10.4103/0973-1482.144356
   PubMed Web of Science ®Google Scholar
• Gao GD, Sun B, Wang XB, et al. Neutrophil to lymphocyte ratio as prognostic indicator for patients with esophageal squamous cell cancer. Int J Biol Markers. 2017;32(4):e409–e414. doi:10.5301/ijbm.5000294
   PubMed Web of Science ®Google Scholar
• Lucca I, Jichlinski P, Shariat SF, et al. The neutrophil-to-lymphocyte ratio as a prognostic factor for patients with urothelial carcinoma of the bladder following radical cystectomy: validation and meta-analysis. Eur Urol Focus. 2016;2(1):79–85. doi:10.1016/j.euf.2015.03.001
   PubMedGoogle Scholar
• Ethier JL, Desautels DN, Templeton AJ, et al. Is the neutrophil-to-lymphocyte ratio prognostic of survival outcomes in gynecologic cancers? A systematic review and meta-analysis. Gynecol Oncol. 2017;145(3):584–594. doi:10.1016/j.ygyno.2017.02.026
   PubMed Web of Science ®Google Scholar
• Jin H, Sun J, Zhu K, et al. The prognostic value of neutrophil-lymphocyte ratio is superior to derived neutrophil-lymphocyte ratio in advanced gastric cancer treated with preoperative chemotherapy and sequential R0 resection: a 5-year follow-up. Onco Targets Ther. 2017;10:2655–2664. doi:10.2147/OTT.S135641
   PubMed Web of Science ®Google Scholar
• Graziosi L, Marino E, De Angelis V, et al. Prognostic value of preoperative neutrophils to lymphocytes ratio in patients resected for gastric cancer. Am J Surg. 2015;209(2):333–337. doi:10.1016/j.amjsurg.2014.06.014
   PubMed Web of Science ®Google Scholar
• Hsu JT, Liao CK, Le PH, et al. Prognostic value of the preoperative neutrophil to lymphocyte ratio in resectable gastric cancer. Medicine. 2015;94(39):e1589. doi:10.1097/MD.0000000000001589
   PubMed Web of Science ®Google Scholar